On this episode of Stock Movers:
- Novo Nordisk (NOVO) shares fall after President Donald Trump said the price of the diabetes drug Ozempic could come down to just $150 a month. Talks over the price of weight-loss drugs, including Ozempic, are still ongoing, according to Mehmet Oz, head of the Centers for Medicare and Medicaid Services.
- State Street (STT) shares drop after the financial manager’s net interest income fell short of expectations in the third quarter. The company’s adjusted earnings per share for the quarter that beat the average analyst estimate.
- Zion (ZION) shares plunge along with Western Alliance after the companies said they were victims of fraud on loans to funds that invest in distressed commercial mortgages. The disclosures add to other recent loan blowups, including subprime auto lender Tricolor Holdings and auto-parts supplier First Brands Group, which triggered losses for some banks.
See omnystudio.com/listener for privacy information.
